Cergentis
Cergentis is a Netherlands-based provider of genetic characterization and QC services, now part of Solvias, built around its Targeted Locus Amplification (TLA) technology platform.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Cergentis is a company in Utrecht, Netherlands, that has become part of Solvias. It brought its Targeted Locus Amplification (TLA) technology platform and expertise in genetic characterization and QC to Solvias to support development of safe and effective advanced therapies. Cergentis continues to serve as a scientific partner for genetic characterization and QC services, offering data security, high-quality reporting, and personal customer service, and it provides Genetic QC Services and Resources.
History
Cergentis is a company in Utrecht, Netherlands. It has become part of Solvias, bringing its Targeted Locus Amplification (TLA) technology platform and expertise in genetic characterization and QC to Solvias to support development of safe and effective advanced therapies. Within Solvias, Cergentis remains a scientific partner for genetic characterization and QC services, with the same data security, high-quality reporting, and personal customer service.
Products and positioning
A familiar and trusted scientific partner for genetic characterization and QC services, now within Solvias, a global CMC analytical services leader.
Targeted Locus Amplification (TLA) technology platform
Cergentis' technology platform and expertise in genetic characterization and QC, brought to Solvias.
Genetic QC Services
Genetic characterization and QC services offered by Cergentis within Solvias.
Recent events
Novalis Biotech Incubation invests in Cergentis[2]
Reported:
Novalis Biotech Incubation, a venture capital investment fund, is investing in Cergentis.
Cergentis appoints CEO and supervisory board members[2]
Reported:
Cergentis announced Joris Schuurmans's appointment as CEO and Dirk Pollet and Maja Sanders's appointments as Supervisory Board members.
Genedata and Cergentis collaborate on TLA workflow automation[3]
Reported:
Genedata said its Selector software solution was developed through close collaboration with Cergentis and joint customers to automate the TLA data analysis workflow.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/cergentis-netherlands · Editorial policy · How profiles are compiled